These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11339893)

  • 21. Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin.
    Qi X; Chang Z; Song J; Gao G; Shen Z
    Anticancer Drugs; 2011 Jul; 22(6):556-62. PubMed ID: 21637162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination therapy with interleukin-2 and wild-type p53 expressed by adenoviral vectors potentiates tumor regression in a murine model of breast cancer.
    Pützer BM; Bramson JL; Addison CL; Hitt M; Siegel PM; Muller WJ; Graham FL
    Hum Gene Ther; 1998 Mar; 9(5):707-18. PubMed ID: 9551618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model.
    Ottewell PD; Lefley DV; Cross SS; Evans CA; Coleman RE; Holen I
    Int J Cancer; 2010 Jan; 126(2):522-32. PubMed ID: 19621384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination therapy with SCH58500 (p53 adenovirus) and cyclophosphamide in preclinical cancer models.
    Nielsen LL
    Oncol Rep; 2000; 7(6):1191-6. PubMed ID: 11032912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo recombinant adenovirus-mediated p53 gene therapy in a syngeneic rat model for colorectal cancer.
    Baek JH; Agarwal ML; Tubbs RR; Vladisavljevic A; Tomita H; Bukowski RM; Milsom JW; Kim JM; Kwak JY
    J Korean Med Sci; 2004 Dec; 19(6):834-41. PubMed ID: 15608394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice.
    Lesoon-Wood LA; Kim WH; Kleinman HK; Weintraub BD; Mixson AJ
    Hum Gene Ther; 1995 Apr; 6(4):395-405. PubMed ID: 7612697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intratumoral expression of mature human neutrophil peptide-1 potentiates the therapeutic effect of doxorubicin in a mouse 4T1 breast cancer model.
    Li D; Qin Q; Wang XY; Shi HS; Luo M; Guo FC; Wang W; Wang YS
    Oncol Rep; 2014 Mar; 31(3):1287-95. PubMed ID: 24378474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo adenovirus-mediated p53 and p16 tumor suppressor therapy in ovarian cancer.
    Modesitt SC; Ramirez P; Zu Z; Bodurka-Bevers D; Gershenson D; Wolf JK
    Clin Cancer Res; 2001 Jun; 7(6):1765-72. PubMed ID: 11410518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts.
    Nielsen LL; Dell J; Maxwell E; Armstrong L; Maneval D; Catino JJ
    Cancer Gene Ther; 1997; 4(2):129-38. PubMed ID: 9080122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 Plays a Key Role in the Apoptosis of Human Ovarian Cancer Cells Induced by Adenovirus-Mediated CRM197.
    Dai L; Pan Q; Peng Y; Huang S; Liu J; Chen T; Wang X; Chen D; Wang J; Zhu Y; Wang H; Liu Y; Ou Y; Yu X; Cao K
    Hum Gene Ther; 2018 Aug; 29(8):916-926. PubMed ID: 29620944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of adenovirus-mediated p16 and p53 genes transfer on apoptosis and cell cycle of lung carcinoma cells].
    Bai X; Che F; Li J; Ma Y; Zhou Y; Zhai J; Meng L
    Zhonghua Bing Li Xue Za Zhi; 2000 Oct; 29(5):354-8. PubMed ID: 11866935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild-type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo.
    Nishizaki M; Meyn RE; Levy LB; Atkinson EN; White RA; Roth JA; Ji L
    Clin Cancer Res; 2001 Sep; 7(9):2887-97. PubMed ID: 11555607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex.
    Nguyen DM; Wiehle SA; Koch PE; Branch C; Yen N; Roth JA; Cristiano RJ
    Cancer Gene Ther; 1997; 4(3):191-8. PubMed ID: 9171938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical study of recombinant adenovirus-p53 (Adp53) combined with hyperthermia in advanced cancer (a report of 15 cases).
    Zhang S; Xu G; Liu C; Xiao S; Sun Y; Su X; Cai Y; Li D; Xu B
    Int J Hyperthermia; 2005 Nov; 21(7):631-6. PubMed ID: 16304714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene therapy for bladder cancer using adenoviral vector.
    Wada Y; Gotoh A; Shirakawa T; Hamada K; Kamidono S
    Mol Urol; 2001; 5(2):47-52. PubMed ID: 11690547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell cycle inhibition therapy that targets stathmin in in vitro and in vivo models of breast cancer.
    Miceli C; Tejada A; Castaneda A; Mistry SJ
    Cancer Gene Ther; 2013 May; 20(5):298-307. PubMed ID: 23618950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer.
    Spitz FR; Nguyen D; Skibber JM; Cusack J; Roth JA; Cristiano RJ
    Anticancer Res; 1996; 16(6B):3415-22. PubMed ID: 9042200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenovirus-mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate, and breast cancer.
    Gurnani M; Lipari P; Dell J; Shi B; Nielsen LL
    Cancer Chemother Pharmacol; 1999; 44(2):143-51. PubMed ID: 10412949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
    Wen SF; Xie L; McDonald M; DiGiacomo R; Chang A; Gurnani M; Shi B; Liu S; Indelicato SR; Hutchins B; Nielsen LL
    Cancer Gene Ther; 2000 Nov; 7(11):1469-80. PubMed ID: 11129289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivo.
    Ottewell PD; Deux B; Mönkkönen H; Cross S; Coleman RE; Clezardin P; Holen I
    Clin Cancer Res; 2008 Jul; 14(14):4658-66. PubMed ID: 18628481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.